TMCnet News
Research and Markets: Chemotherapy Induced Myelosuppression - Pipeline Review, H2 2013 Research ReportDUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/p9m7xt/chemotherapy) has announced the addition of the "Chemotherapy Induced Myelosuppression - Pipeline Review, H2 2013" report to their offering. 'Chemotherapy Induced Myelosuppression - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Chemotherapy Induced Myelosuppression, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Chemotherapy Induced Myelosuppression. Scope - A snapshot of the global therapeutic scenario for Chemotherapy Induced Myelosuppression. - A review of the Chemotherapy Induced Myelosuppression products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discover till registration stages. - A feature on pipeline projects on the basis of monotherapy and combined therapeutics. - Coverage of the Chemotherapy Induced Myelosuppression pipeline on the basis of route of administration and molecule type. - Key discontinued pipeline projects. - Latest news and deals relating to the products. Key Topics Covered: Introduction Chemotherapy Induced Myelosuppression Overview Therapeutics Development Pipeline Products for Chemotherapy Induced Myelosuppression - Overview Pipeline Products for Chemotherapy Induced Myelosuppression - Comparative Analysis Chemotherapy Induced Myelosuppression - Therapeutics under Development by Companies Chemotherapy Induced Myelosuppression - Therapeutics under Investigation by Universities/Institutes Chemotherapy Induced Myelosuppression - Pipeline Products Glance Clinical Stage Products Early Stage Products Chemotherapy Induced Myelosuppression - Products under Development by Companies Chemotherapy Induced Myelosuppression - Products under Investigation by Universities/Institutes Chemotherapy Induced Myelosuppression - Companies Involved in Therapeutics Development Biothera, Inc. G1 Therapeutics, Inc. Berg Pharma, LLC Chemotherapy Induced Myelosuppression - Therapeutics Assessment Drug Profiles PGG beta-glucan - Drug Profile calcitriol - Drug Profile dinoprostone - Drug Profile GZ-381 - Drug Profile SHIP1 Inhibitors - Drug Profile Chemotherapy Induced Myelosuppression - Recent Pipeline Updates Chemotherapy Induced Myelosuppression - Dormant Projects Companies Mentioned Biothera, Inc. G1 Therapeutics, Inc. Berg Pharma, LLC For more information visit http://www.researchandmarkets.com/research/p9m7xt/chemotherapy About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
|